D'Orazio & Associates’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-104
Closed -$3K 331
2019
Q4
$3K Hold
104
﹤0.01% 296
2019
Q3
$2K Hold
104
﹤0.01% 309
2019
Q2
$2K Hold
104
﹤0.01% 299
2019
Q1
$2K Hold
104
﹤0.01% 308
2018
Q4
$2K Hold
104
﹤0.01% 266
2018
Q3
$2K Hold
104
﹤0.01% 255
2018
Q2
$2K Hold
104
﹤0.01% 244
2018
Q1
$3K Hold
104
﹤0.01% 249
2017
Q4
$3K Buy
+104
New +$3.27K ﹤0.01% 283
2017
Q3
Sell
-104
Closed -$2K 269
2017
Q2
$2K Buy
+104
New +$2.2K ﹤0.01% 291

Other funds holding ACLS

D'Orazio & Associates's ACLS Position: Q1 2020 in Review

D'Orazio & Associates sold out of Axcelis (ACLS) in Q1 2020, closing a stake of 104 shares — an estimated $3K sold.

D'Orazio & Associates first reported a position in ACLS in Q2 2017 and held it in 10 quarters. The position peaked at $3K in Q4 2019. 140 funds tracked by Wall St. Rank hold ACLS as of Q1 2020.

  • D'Orazio & Associates reported no remaining Axcelis position as of Q1 2020 after selling out during the quarter.
  • D'Orazio & Associates sold 104 Axcelis shares in Q1 2020, an estimated $3K.
  • D'Orazio & Associates first reported a position in Axcelis in Q2 2017 and held it in 10 quarters.
  • D'Orazio & Associates's Axcelis position peaked at $3K in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Axcelis as of Q1 2020.

Based on D'Orazio & Associates's 13F filing for Q1 2020, filed 28 Apr 2020.